Although the screening of anticancer activity of natural products in cell lines is cost-effective and time saving, but it lacks some key advantages of in vivo assays.
While R excels in its flexibility, graphics, and statistical power, it lacks some of the built in data documentation features present in other statistical packages.
However, Paul Milgrom, an economist at Stanford, is sceptical about its long-term prospects, because it lacks some crucial ingredients.
But still it lacks some desired properties, which limits its uses in many other applications.
However, it lacks some of the functionality of its sibling, resulting in a paucity of compatible software.
It lacks some of the processing oomph of its desktop counterparts, but it's still impressive output for a 13-inch laptop.
Exendin-4 has a Gly 8 in place of an Ala 8 of the N-terminus, and therefore, is not a substrate for DPP 4. In addition, it lacks some of the target bonds for NEP 24.11, and its secondary and tertiary structures may also prevent NEP 24.11 hydrolysis, thus leading to a prolonged half-life.
However, it lacks some practical data exchange functions.
It lacks some of the elegance of the Obama approach.
It lacks some of the bells and whistles that more professional systems offer.
It has seeds, sure, but it lacks some of the personality of the older varieties.
